binge eating semaglutide GLP-1s, Obesity, Emotional Eating, and Binge Eating Disorder - Diagnosis
Description
Effects are temporary : The blood sugar-lowering effects typically last only a few hours

Suitable for adults with a BMI of 30 or greater (or 27 and above with related conditions), Wegovy has shown promising results in trials, offering an average weight loss of 15% over 68 weeks

In: Wade T (ed) in Encyclopedia of Feeding and Eating disorders

Research Applications Both peptides are studied in laboratory settings involving metabolic signaling, receptor binding, and cellular response pathways

Or they may recommend a medication other than metformin for you
Four other patients started the study but withdrew and returned to the standard weekly dosing schedule after gaining some weight before their first three-month follow-up visit for the trial